Nextremity Solutions Gains FDA Clearance for Metatarsophalangeal Joint Arthrodesis System

Nextremity Solutions received FDA 510(k) clearance to market its InCore® Metatarsophalangeal Joint (MPJ) System, a three-part construct intended for internal fixation for First Metatarsophalangeal Joint Arthrodesis.

InCore MPJ instrumentation provides compression and stability to the fixation site prior to implant placement. The system joins...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us